Related Experiment Videos
Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells
G P Raaphorst1, J Miao, D Stewart
1Medical Physics Department, Ottawa Regional Cancer Centre, Ontario, Canada.
Purpose:
Human ovarian cancer cells were evaluated to determine whether combination treatment with mild hyperthermia and cisplatin could inhibit repair of sublethal radiation damage.
Materials And Methods:
Human ovarian carcinoma cell lines A2780S (parental line) and A2780CP (cisplatin resistant variant) were used in this study. Cisplatin at concentrations of 1 or 3 microg/ml was given concomitantly with 1 h of heating at 40 degrees C either immediately before or after irradiation. Survival was determined using a colony-forming assay.
Results:
Neither mild hyperthermia nor cisplatin treatments alone affected sublethal damage repair. The combined treatment showed an effect in both cell lines and was treatment sequence-dependent. The effect was greater in the parental cell line.
Conclusions:
The data show that combined treatment of cisplatin and hyperthermia may have clinical efficacy at cisplatin concentrations and hyperthermia temperatures which by themselves have little to no effect.